Chlorine in PDB 1p45: Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Enzymatic activity of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
All present enzymatic activity of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data:
1.3.1.9;
Protein crystallography data
The structure of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data, PDB code: 1p45
was solved by
M.R.Kuo,
H.R.Morbidoni,
D.Alland,
S.F.Sneddon,
B.B.Gourlie,
M.M.Staveski,
M.Leonard,
J.S.Gregory,
A.D.Janjigian,
C.Yee,
J.M.Musser,
B.N.Kreiswirth,
H.Iwamoto,
R.Perozzo,
W.R.Jacobs Jr.,
J.C.Sacchettini,
D.A.Fidock,
Tbstructural Genomics Consortium (Tbsgc),
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
30.00 /
2.60
|
Space group
|
I 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
94.822,
104.120,
189.746,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
22.5 /
29
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
(pdb code 1p45). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 9 binding sites of Chlorine where determined in the
Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data, PDB code: 1p45:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
Chlorine binding site 1 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 1 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl400
b:55.5
occ:1.00
|
CL14
|
A:TCL400
|
0.0
|
55.5
|
1.0
|
C2
|
A:TCL400
|
1.7
|
54.3
|
1.0
|
C1
|
A:TCL400
|
2.7
|
56.5
|
1.0
|
C3
|
A:TCL400
|
2.7
|
52.9
|
1.0
|
C3
|
A:TCL450
|
3.2
|
66.4
|
1.0
|
C2
|
A:TCL450
|
3.4
|
68.0
|
1.0
|
CZ
|
A:PHE149
|
3.4
|
30.9
|
1.0
|
CE2
|
A:PHE149
|
3.5
|
24.1
|
1.0
|
CL14
|
A:TCL450
|
3.6
|
72.0
|
1.0
|
CE1
|
A:PHE149
|
3.8
|
31.8
|
1.0
|
C4
|
A:TCL450
|
3.9
|
66.8
|
1.0
|
CD2
|
A:PHE149
|
4.0
|
32.2
|
1.0
|
C6
|
A:TCL400
|
4.0
|
52.7
|
1.0
|
C4
|
A:TCL400
|
4.0
|
50.0
|
1.0
|
CD1
|
A:PHE149
|
4.2
|
35.9
|
1.0
|
C1
|
A:TCL450
|
4.2
|
68.9
|
1.0
|
CB
|
A:PRO193
|
4.2
|
41.0
|
1.0
|
O7N
|
A:NAD300
|
4.2
|
57.6
|
1.0
|
CG
|
A:PRO193
|
4.2
|
41.8
|
1.0
|
CG
|
A:PHE149
|
4.3
|
34.3
|
1.0
|
CA
|
A:PRO193
|
4.3
|
42.1
|
1.0
|
CE
|
A:MET199
|
4.5
|
64.3
|
1.0
|
C5
|
A:TCL400
|
4.5
|
52.2
|
1.0
|
C4N
|
A:NAD300
|
4.6
|
54.7
|
1.0
|
C5
|
A:TCL450
|
4.6
|
67.3
|
1.0
|
C6
|
A:TCL450
|
4.7
|
68.7
|
1.0
|
C7N
|
A:NAD300
|
4.8
|
49.6
|
1.0
|
N
|
A:PRO193
|
4.9
|
41.9
|
1.0
|
SD
|
A:MET199
|
4.9
|
64.8
|
1.0
|
C3N
|
A:NAD300
|
5.0
|
53.2
|
1.0
|
|
Chlorine binding site 2 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 2 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl400
b:56.6
occ:1.00
|
CL15
|
A:TCL400
|
0.0
|
56.6
|
1.0
|
C11
|
A:TCL400
|
1.7
|
57.9
|
1.0
|
C12
|
A:TCL400
|
2.7
|
58.2
|
1.0
|
C10
|
A:TCL400
|
2.8
|
53.5
|
1.0
|
N
|
A:MET98
|
3.3
|
45.5
|
1.0
|
O
|
A:MET98
|
3.4
|
49.8
|
1.0
|
C9
|
A:TCL400
|
4.0
|
54.4
|
1.0
|
CA
|
A:PHE97
|
4.0
|
43.9
|
1.0
|
C13
|
A:TCL400
|
4.0
|
55.4
|
1.0
|
CL15
|
A:TCL450
|
4.1
|
69.3
|
1.0
|
C
|
A:PHE97
|
4.2
|
44.3
|
1.0
|
CA
|
A:MET98
|
4.2
|
47.4
|
1.0
|
C
|
A:MET98
|
4.2
|
49.0
|
1.0
|
CD1
|
A:PHE97
|
4.2
|
50.2
|
1.0
|
SD
|
A:MET103
|
4.2
|
54.7
|
1.0
|
CB
|
A:MET98
|
4.4
|
47.4
|
1.0
|
C8
|
A:TCL400
|
4.6
|
54.4
|
1.0
|
CE1
|
A:PHE97
|
4.7
|
49.0
|
1.0
|
CG
|
A:PHE97
|
4.8
|
45.2
|
1.0
|
C11
|
A:TCL450
|
4.9
|
62.1
|
1.0
|
CB
|
A:PHE97
|
4.9
|
44.0
|
1.0
|
O
|
A:GLY96
|
5.0
|
45.1
|
1.0
|
|
Chlorine binding site 3 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 3 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl400
b:64.2
occ:1.00
|
CL16
|
A:TCL400
|
0.0
|
64.2
|
1.0
|
C9
|
A:TCL400
|
1.7
|
54.4
|
1.0
|
C10
|
A:TCL400
|
2.6
|
53.5
|
1.0
|
C8
|
A:TCL400
|
2.7
|
54.4
|
1.0
|
O7
|
A:TCL400
|
2.9
|
53.3
|
1.0
|
O5D
|
A:NAD300
|
3.2
|
42.4
|
1.0
|
C2D
|
A:NAD300
|
3.5
|
40.4
|
1.0
|
O
|
A:GLY96
|
3.5
|
45.1
|
1.0
|
O3
|
A:NAD300
|
3.6
|
45.1
|
1.0
|
O2D
|
A:NAD300
|
3.7
|
38.5
|
1.0
|
C3D
|
A:NAD300
|
3.8
|
41.8
|
1.0
|
C5B
|
A:NAD300
|
3.9
|
48.8
|
1.0
|
C11
|
A:TCL400
|
3.9
|
57.9
|
1.0
|
C13
|
A:TCL400
|
4.0
|
55.4
|
1.0
|
C
|
A:GLY96
|
4.1
|
44.0
|
1.0
|
C5D
|
A:NAD300
|
4.1
|
43.3
|
1.0
|
O5B
|
A:NAD300
|
4.2
|
44.3
|
1.0
|
C5
|
A:TCL400
|
4.2
|
52.2
|
1.0
|
PA
|
A:NAD300
|
4.2
|
42.8
|
1.0
|
PN
|
A:NAD300
|
4.2
|
47.7
|
1.0
|
CA
|
A:GLY96
|
4.3
|
44.0
|
1.0
|
O1A
|
A:NAD300
|
4.3
|
41.8
|
1.0
|
C12
|
A:TCL400
|
4.4
|
58.2
|
1.0
|
C4D
|
A:NAD300
|
4.5
|
42.7
|
1.0
|
O2N
|
A:NAD300
|
4.7
|
46.6
|
1.0
|
N
|
A:GLY96
|
4.7
|
43.8
|
1.0
|
C1D
|
A:NAD300
|
4.9
|
41.9
|
1.0
|
C4
|
A:TCL400
|
4.9
|
50.0
|
1.0
|
O3D
|
A:NAD300
|
5.0
|
42.4
|
1.0
|
N
|
A:PHE97
|
5.0
|
43.4
|
1.0
|
|
Chlorine binding site 4 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 4 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl450
b:72.0
occ:1.00
|
CL14
|
A:TCL450
|
0.0
|
72.0
|
1.0
|
C2
|
A:TCL450
|
1.8
|
68.0
|
1.0
|
C3
|
A:TCL450
|
2.7
|
66.4
|
1.0
|
C1
|
A:TCL450
|
2.7
|
68.9
|
1.0
|
CD2
|
A:LEU218
|
3.5
|
64.5
|
1.0
|
CL14
|
A:TCL400
|
3.6
|
55.5
|
1.0
|
CG
|
A:LEU218
|
3.7
|
64.0
|
1.0
|
CG
|
A:PRO193
|
3.9
|
41.8
|
1.0
|
CZ
|
A:PHE149
|
4.0
|
30.9
|
1.0
|
C6
|
A:TCL450
|
4.0
|
68.7
|
1.0
|
C4
|
A:TCL450
|
4.0
|
66.8
|
1.0
|
CZ3
|
A:TRP222
|
4.0
|
43.9
|
1.0
|
CA
|
A:GLU219
|
4.1
|
60.3
|
1.0
|
N
|
A:GLU219
|
4.3
|
60.4
|
1.0
|
CB
|
A:PRO193
|
4.4
|
41.0
|
1.0
|
CG
|
A:GLU219
|
4.4
|
62.8
|
1.0
|
CE1
|
A:PHE149
|
4.5
|
31.8
|
1.0
|
C5
|
A:TCL450
|
4.5
|
67.3
|
1.0
|
CD1
|
A:LEU218
|
4.5
|
61.6
|
1.0
|
CB
|
A:GLU219
|
4.5
|
61.1
|
1.0
|
CE3
|
A:TRP222
|
4.6
|
44.2
|
1.0
|
CH2
|
A:TRP222
|
4.7
|
36.7
|
1.0
|
C
|
A:LEU218
|
4.8
|
61.4
|
1.0
|
CB
|
A:LEU218
|
4.8
|
62.7
|
1.0
|
CE2
|
A:PHE149
|
4.8
|
24.1
|
1.0
|
|
Chlorine binding site 5 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 5 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl450
b:69.3
occ:1.00
|
CL15
|
A:TCL450
|
0.0
|
69.3
|
1.0
|
C11
|
A:TCL450
|
1.7
|
62.1
|
1.0
|
C10
|
A:TCL450
|
2.6
|
64.1
|
1.0
|
C12
|
A:TCL450
|
2.7
|
63.0
|
1.0
|
C12
|
A:TCL400
|
3.6
|
58.2
|
1.0
|
C11
|
A:TCL400
|
3.8
|
57.9
|
1.0
|
C9
|
A:TCL450
|
3.9
|
67.0
|
1.0
|
C13
|
A:TCL450
|
4.0
|
64.8
|
1.0
|
C13
|
A:TCL400
|
4.1
|
55.4
|
1.0
|
CL15
|
A:TCL400
|
4.1
|
56.6
|
1.0
|
CB
|
A:ALA198
|
4.2
|
53.8
|
1.0
|
OE1
|
A:GLN100
|
4.4
|
68.5
|
1.0
|
C8
|
A:TCL450
|
4.4
|
65.3
|
1.0
|
C10
|
A:TCL400
|
4.6
|
53.5
|
1.0
|
C8
|
A:TCL400
|
4.8
|
54.4
|
1.0
|
CG2
|
A:ILE202
|
5.0
|
60.1
|
1.0
|
C9
|
A:TCL400
|
5.0
|
54.4
|
1.0
|
|
Chlorine binding site 6 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 6 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl450
b:75.3
occ:1.00
|
CL16
|
A:TCL450
|
0.0
|
75.3
|
1.0
|
C9
|
A:TCL450
|
1.8
|
67.0
|
1.0
|
C10
|
A:TCL450
|
2.7
|
64.1
|
1.0
|
C8
|
A:TCL450
|
2.8
|
65.3
|
1.0
|
O7
|
A:TCL450
|
2.8
|
66.3
|
1.0
|
N
|
A:GLY104
|
3.4
|
58.1
|
1.0
|
CA
|
A:GLY104
|
3.7
|
59.4
|
1.0
|
C11
|
A:TCL450
|
4.0
|
62.1
|
1.0
|
CB
|
A:MET103
|
4.1
|
54.9
|
1.0
|
C13
|
A:TCL450
|
4.1
|
64.8
|
1.0
|
O17
|
A:TCL450
|
4.1
|
73.9
|
1.0
|
C5
|
A:TCL450
|
4.1
|
67.3
|
1.0
|
CD2
|
A:LEU207
|
4.1
|
60.6
|
1.0
|
CE
|
A:MET103
|
4.2
|
43.4
|
1.0
|
C
|
A:MET103
|
4.4
|
55.9
|
1.0
|
O
|
A:ALA157
|
4.4
|
51.5
|
1.0
|
OE1
|
A:GLN100
|
4.4
|
68.5
|
1.0
|
CB
|
A:ALA157
|
4.5
|
48.6
|
1.0
|
C12
|
A:TCL450
|
4.6
|
63.0
|
1.0
|
C6
|
A:TCL450
|
4.7
|
68.7
|
1.0
|
C
|
A:ALA157
|
4.7
|
49.7
|
1.0
|
CA
|
A:MET103
|
4.8
|
54.3
|
1.0
|
SD
|
A:MET103
|
4.9
|
54.7
|
1.0
|
CA
|
A:ALA157
|
4.9
|
48.9
|
1.0
|
CD1
|
A:ILE215
|
4.9
|
67.0
|
1.0
|
NE2
|
A:GLN100
|
5.0
|
66.2
|
1.0
|
|
Chlorine binding site 7 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 7 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 7 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl500
b:45.5
occ:1.00
|
CL14
|
B:TCL500
|
0.0
|
45.5
|
1.0
|
C2
|
B:TCL500
|
1.7
|
50.4
|
1.0
|
C3
|
B:TCL500
|
2.7
|
50.0
|
1.0
|
C1
|
B:TCL500
|
2.7
|
50.9
|
1.0
|
CE1
|
B:PHE149
|
3.6
|
34.1
|
1.0
|
O7N
|
B:NAD350
|
3.6
|
57.9
|
1.0
|
CZ
|
B:PHE149
|
3.6
|
37.0
|
1.0
|
CD1
|
B:PHE149
|
3.9
|
30.6
|
1.0
|
C4
|
B:TCL500
|
4.0
|
49.0
|
1.0
|
CB
|
B:PRO193
|
4.0
|
46.7
|
1.0
|
C6
|
B:TCL500
|
4.0
|
49.9
|
1.0
|
CE2
|
B:PHE149
|
4.1
|
40.6
|
1.0
|
CA
|
B:PRO193
|
4.2
|
46.9
|
1.0
|
C4N
|
B:NAD350
|
4.2
|
61.7
|
1.0
|
C7N
|
B:NAD350
|
4.3
|
59.8
|
1.0
|
CG
|
B:PHE149
|
4.4
|
35.4
|
1.0
|
CD2
|
B:PHE149
|
4.4
|
39.7
|
1.0
|
C5
|
B:TCL500
|
4.5
|
49.6
|
1.0
|
C3N
|
B:NAD350
|
4.5
|
61.1
|
1.0
|
CD2
|
B:LEU218
|
4.9
|
53.5
|
1.0
|
|
Chlorine binding site 8 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 8 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 8 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl500
b:57.1
occ:1.00
|
CL15
|
B:TCL500
|
0.0
|
57.1
|
1.0
|
C11
|
B:TCL500
|
1.8
|
54.2
|
1.0
|
C12
|
B:TCL500
|
2.7
|
48.9
|
1.0
|
C10
|
B:TCL500
|
2.8
|
53.0
|
1.0
|
N
|
B:MET98
|
3.2
|
42.5
|
1.0
|
CE
|
B:MET103
|
3.3
|
56.2
|
1.0
|
O
|
B:MET98
|
3.3
|
45.2
|
1.0
|
O
|
B:HOH513
|
3.9
|
43.4
|
1.0
|
CA
|
B:MET98
|
3.9
|
44.6
|
1.0
|
CB
|
B:MET98
|
3.9
|
45.2
|
1.0
|
CA
|
B:PHE97
|
4.0
|
39.9
|
1.0
|
C
|
B:PHE97
|
4.0
|
41.0
|
1.0
|
C13
|
B:TCL500
|
4.0
|
46.8
|
1.0
|
C
|
B:MET98
|
4.1
|
45.6
|
1.0
|
C9
|
B:TCL500
|
4.1
|
52.0
|
1.0
|
CE
|
B:MET161
|
4.2
|
50.0
|
1.0
|
CD1
|
B:ILE202
|
4.3
|
89.1
|
1.0
|
CD1
|
B:PHE97
|
4.3
|
35.4
|
1.0
|
C8
|
B:TCL500
|
4.6
|
48.9
|
1.0
|
CG
|
B:PHE97
|
4.8
|
38.7
|
1.0
|
SD
|
B:MET103
|
4.8
|
58.7
|
1.0
|
CE1
|
B:PHE97
|
4.8
|
40.3
|
1.0
|
N
|
B:PHE97
|
4.9
|
39.4
|
1.0
|
CB
|
B:PHE97
|
4.9
|
40.1
|
1.0
|
|
Chlorine binding site 9 out
of 9 in 1p45
Go back to
Chlorine Binding Sites List in 1p45
Chlorine binding site 9 out
of 9 in the Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 9 of Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl500
b:69.6
occ:1.00
|
CL16
|
B:TCL500
|
0.0
|
69.6
|
1.0
|
C9
|
B:TCL500
|
1.8
|
52.0
|
1.0
|
C8
|
B:TCL500
|
2.8
|
48.9
|
1.0
|
C10
|
B:TCL500
|
2.8
|
53.0
|
1.0
|
O7
|
B:TCL500
|
3.0
|
48.8
|
1.0
|
O5D
|
B:NAD350
|
3.2
|
50.1
|
1.0
|
C2D
|
B:NAD350
|
3.3
|
53.9
|
1.0
|
O3
|
B:NAD350
|
3.5
|
44.4
|
1.0
|
O2D
|
B:NAD350
|
3.5
|
58.4
|
1.0
|
C3D
|
B:NAD350
|
3.6
|
52.4
|
1.0
|
C5B
|
B:NAD350
|
3.7
|
46.2
|
1.0
|
O
|
B:GLY96
|
3.8
|
39.4
|
1.0
|
PN
|
B:NAD350
|
4.0
|
49.1
|
1.0
|
CB
|
B:ALA198
|
4.0
|
73.0
|
1.0
|
C13
|
B:TCL500
|
4.0
|
46.8
|
1.0
|
C
|
B:GLY96
|
4.1
|
39.9
|
1.0
|
C11
|
B:TCL500
|
4.1
|
54.2
|
1.0
|
O2N
|
B:NAD350
|
4.1
|
48.0
|
1.0
|
O5B
|
B:NAD350
|
4.2
|
44.1
|
1.0
|
N
|
B:GLY96
|
4.2
|
39.9
|
1.0
|
CA
|
B:GLY96
|
4.2
|
39.3
|
1.0
|
O1A
|
B:NAD350
|
4.3
|
41.1
|
1.0
|
PA
|
B:NAD350
|
4.3
|
42.3
|
1.0
|
C5
|
B:TCL500
|
4.3
|
49.6
|
1.0
|
C5D
|
B:NAD350
|
4.3
|
50.4
|
1.0
|
C4D
|
B:NAD350
|
4.5
|
52.4
|
1.0
|
C12
|
B:TCL500
|
4.5
|
48.9
|
1.0
|
O3D
|
B:NAD350
|
4.7
|
50.0
|
1.0
|
C1D
|
B:NAD350
|
4.8
|
56.3
|
1.0
|
CE
|
B:MET161
|
4.8
|
50.0
|
1.0
|
O
|
B:ALA198
|
4.8
|
74.9
|
1.0
|
N
|
B:PHE97
|
4.9
|
39.4
|
1.0
|
|
Reference:
M.R.Kuo,
H.R.Morbidoni,
D.Alland,
S.F.Sneddon,
B.B.Gourlie,
M.M.Staveski,
M.Leonard,
J.S.Gregory,
A.D.Janjigian,
C.Yee,
J.M.Musser,
B.Kreiswirth,
H.Iwamoto,
R.Perozzo,
W.R.Jacobs,
J.C.Sacchettini,
D.A.Fidock.
Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data. J.Biol.Chem. V. 278 20851 2003.
ISSN: ISSN 0021-9258
PubMed: 12606558
DOI: 10.1074/JBC.M211968200
Page generated: Sat Jul 20 01:08:10 2024
|